Homocysteine is a harmful amino acid. B-vitamins change it into helpful compounds;  SAM and glutathione.  Without sufficient B-vitamins homocysteine levels rise.  Homocysteine also increases with age and smoking

High homocysteine levels are associated with an increased risk of cardiovascular and neuropsychiatric diseases, including stroke and dementia

COBALZ developed from a study of B12 in Alzheimer's dementia and the discovery of high blood levels of homocysteine in the disease

Homocysteine predicts cognitive decline; a high level is a risk factor for dementia and brain shrinkage

COBALZ found that N-acetylcysteine (NAC), used together with B vitamins, markedly lowers homocysteine leading to clinical improvement in patients with memory problems

Cerefolin NAC, incorporating COBALZ technology, is now available as a ‘medical food’ in the US

NEW PRODUCT!     BETRINAC to be launched in First Quarter 2012!

Neil McCaddon - COBALZ Limited